Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1990Clinical Infectious Diseases

The National Cancer Institute Phase I Study of 2′,3′-Dideoxyinosine Administration in Adults with AIDS or AIDS-Related Complex: Analysis of Activity and Toxicity Profiles

View Full Paper
Ask AI
Bookmark
Share

Authors

RYRobert YarchoanNational Institutes of HealthHMHiroaki MitsuyaNational Institutes of HealthJPJames M. PludaNational Cancer Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yarchoan et al. (1990) studied this question.

synapsesocial.com/papers/6a9ff68b60d48b6184618b1ehttps://doi.org/10.1093/clinids/12.supplement_5.s522
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine1989 · 426 citations
  2. 22′,3′-Dideoxyinosine in Patients with AIDS or AIDS-Related Complex1990 · 51 citations
  3. 3Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program1988 · 168 citations
  4. 4Pancreatitis associated with pentamidine by aerosol.1989 · 46 citations